So, GRK5-Leu41 represents a gain-of-function polymorphism that evokes enhanced loss-of-function of β2-AR during persistent agonist exposure, thus possibly contributing to β2-AR agonist variability in asthma treatment of African-Americans [111]. This evidence concerns the gene ADRB2 and asthma.